Diabetologia

, Volume 39, Issue 3, pp 368–370

The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved

  • R. Bender
  • K. S. L. Lam
  • I. J. Lauder
Letter to the Editors

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609Google Scholar
  2. 2.
    Andersen B (1990) Methodological errors in medical research. Blackwell, Oxford London Edinburgh Boston Melbourne Paris Berlin ViennaGoogle Scholar
  3. 3.
    Crowder MJ, Hand DJ (1990) Analysis of repeated measures. Chapman and Hall, London New York Tokyo Melbourne MadrasGoogle Scholar
  4. 4.
    Senn S (1994) Testing for baseline balance in clinical trials. Stat Med 13: 1715–1726Google Scholar
  5. 5.
    Matthews JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300: 230–235Google Scholar

References

  1. 1a.
    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • R. Bender
    • 1
  • K. S. L. Lam
    • 2
  • I. J. Lauder
    • 2
  1. 1.Department of Metabolic Diseases and NutritionHeinrich-Heine-Universität DüsseldorfDüsseldorfGermany
  2. 2.Departments of MedicineThe University of Hong KongHong Kong

Personalised recommendations